Abstract
We report the first case of a critically ill pediatric patient coinfected with coronavirus disease 2019 (COVID-19) and Pneumocystis jirovecii pneumonia (PCP). Instances of coinfection of COVID-19 and PCP are being increasingly reported as the COVID-19 pandemic continues. Because the combination can be life-threatening, timely diagnosis and treatment for PCP is necessary in cases where an immunocompromised patient contracts COVID-19.
| Original language | English |
|---|---|
| Article number | e23477 |
| Journal | Heliyon |
| Volume | 10 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2024.01.15 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Coinfection
- Coronaviurs disease 2019 (COVID-19)
- Corticosteroids
- Immunocompromised children
- Pneumocystis jirovecii pneumonia (PCP)
- SARS-CoV-2
Fingerprint
Dive into the research topics of 'Case Report of COVID-19 and Pneumocystis coinfection in a pediatric patient with a history of receiving high dose steroid therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver